Safety and efficacy of dexamethasone intravitreal implant given either first-line or second-line in diabetic macular edema
A Taloni, G Coco, D Rastelli, G Buffon… - Patient preference …, 2023 - Taylor & Francis
Diabetic macular edema (DME) is a common sight-threatening complication of diabetic
retinopathy (DR) and the leading cause of severe visual impairment among the working-age …
retinopathy (DR) and the leading cause of severe visual impairment among the working-age …
[HTML][HTML] Efficacy and Safety of Fluocinolone Acetonide Implant in Diabetic Macular Edema: Practical Guidelines from Reference Center
L Sejournet, T Mathis, V Vermot-Desroches, R Serra… - Pharmaceutics, 2024 - mdpi.com
Diabetic macular edema (DME) is a common complication of diabetic retinopathy. Treatment
with intravitreal injections is effective in most cases but is associated with a high therapeutic …
with intravitreal injections is effective in most cases but is associated with a high therapeutic …
[HTML][HTML] Fluocinolone acetonide implant (FAci) one month after dexamethasone implant (DEXi) for chronic diabetic macular edema: 1-year results
Q Lampin, J Poret, M Gherras, B Jany… - Journal Français d' …, 2025 - Elsevier
Purpose To evaluate the safety and efficacy of FACi injected 1 month after the last DEXi
injection in pseudophakic patients without ocular hypertension who required frequent DEXi …
injection in pseudophakic patients without ocular hypertension who required frequent DEXi …